Literature DB >> 7128545

Plasma vasopressin and oxytocin in response to exercise and during a day-night cycle in man.

R Landgraf, R Häcker, H Buhl.   

Abstract

Plasma vasopressin (AVP) and oxytocin (OXT) were determined by radioimmunoassay in healthy young men before, during and after a running exercise until exhaustion. In four of the five test subjects (one subject was underloaded) physical load resulted in a marked increase in plasma AVP with peak values of 11.7 to 57.8 pg/ml at exhaustion. Plasma OXT increased in three test subjects with peak values of 4.5 to 23.9 pg/ml. Within 1 h of recovery, both neuropeptides returned to basal plasma levels. The relationship between plasma AVP and osmolality (p less than 0.001) suggests that changes in osmolality play a dominant role in regulating the secretion of AVP. Besides peripheral effects, the increased levels of AVP and/or OXT during and immediately after the exercise, respectively, might induce a favourable action on the brain function. Determination of plasma AVP and OXT during a day-night cycle in the same test subjects reveals increased AVP levels from 02.00 to 08.00 h as compared to the other time periods chosen (18.00--24.00 h, p less than 0.001; 08.00--16.00 h, p = 0.031). In contrast, OXT does not differ between these time periods but decreased from 08.00 to 16.00 h (p less than 0.01). Accordingly, no correlation exists between both neuropeptides suggesting an independent secretion. It is unclear whether the circadian variations shown are able to influence the neuropeptide response to exercise.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7128545

Source DB:  PubMed          Journal:  Endokrinologie        ISSN: 0013-7251


  13 in total

1.  Neurones in the supraoptic nucleus of the rat are regulated by a projection from the suprachiasmatic nucleus.

Authors:  L N Cui; K Saeb-Parsy; R E Dyball
Journal:  J Physiol       Date:  1997-07-01       Impact factor: 5.182

Review 2.  Arginine vasopressin, fluid balance and exercise: is exercise-associated hyponatraemia a disorder of arginine vasopressin secretion?

Authors:  Tamara Hew-Butler
Journal:  Sports Med       Date:  2010-06-01       Impact factor: 11.136

Review 3.  Advances in human oxytocin measurement: challenges and proposed solutions.

Authors:  Benjamin A Tabak; Gareth Leng; Angela Szeto; Karen J Parker; Joseph G Verbalis; Toni E Ziegler; Mary R Lee; Inga D Neumann; Armando J Mendez
Journal:  Mol Psychiatry       Date:  2022-08-23       Impact factor: 13.437

4.  Plasma vasopressin, renin activity, and aldosterone responses to maximal exercise in active college females.

Authors:  C M Maresh; B C Wang; K L Goetz
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1985

5.  The roles of testosterone and alpha-amylase in exercise-induced sexual arousal in women.

Authors:  Lisa Dawn Hamilton; Emily A Fogle; Cindy M Meston
Journal:  J Sex Med       Date:  2008-01-21       Impact factor: 3.802

6.  Vasopressin-mediated forearm vasodilation in normal humans. Evidence for a vascular vasopressin V2 receptor.

Authors:  A T Hirsch; V J Dzau; J A Majzoub; M A Creager
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

7.  Circadian rhythms in urinary functions: possible roles of circadian clocks?

Authors:  Jong-Yun Noh; Dong-Hee Han; Ji-Ae Yoon; Mi-Hee Kim; Sung-Eun Kim; Il-Gyu Ko; Khae-Hawn Kim; Chang-Ju Kim; Sehyung Cho
Journal:  Int Neurourol J       Date:  2011-06-30       Impact factor: 2.835

8.  Oral Contraceptives and Renal Water Handling: A diurnal study in young women.

Authors:  Charlotte Graugaard-Jensen; Gitte M Hvistendahl; Jørgen Frøkiær; Peter Bie; Jens Christian Djurhuus
Journal:  Physiol Rep       Date:  2017-12

9.  Helping oxytocin deliver: considerations in the development of oxytocin-based therapeutics for brain disorders.

Authors:  K Macdonald; D Feifel
Journal:  Front Neurosci       Date:  2013-03-15       Impact factor: 4.677

10.  The influence of high and low levels of estrogen on diurnal urine regulation in young women.

Authors:  Charlotte Graugaard-Jensen; Gitte M Hvistendahl; Jørgen Frøkiaer; Peter Bie; Jens Christian Djurhuus
Journal:  BMC Urol       Date:  2008-11-19       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.